Abstract:Diabetic kidney disease (DKD) is a complication of diabetes, which is the most common cause of end-stage renal disease (dialysis). DKD has a high mortality rate, and only early detection can nip this disease in the bud. Advanced glycation end products (AGEs)are generally believed to be involved in the occurrence of DKD. Studies have shown that the lens AGEs fluorescence for noninvasive detection has high consistency with the gold standard OGTT, has high sensitivity and specificity, and could be used as a practical tool for the early screening of type 2 diabetes mellitus (T2DM).Therefore, we speculated that the noninvasive lens AGEs fluorescence detection method can be used to predict the occurrence of DKD. This study detected levels of AGEs in multiple cellular and tissues and analyzed the relationships between AGEs and lens, eyeballs, peripheral blood mononuclear cell (PBMC), serum, and kidney. Additionally, we examined the possible role of lens AGEs fluorescence in DKD screening. Our preexperimental study found that lens AGE levels in patients with T2DM were positively correlated with PBM and serum AGE levels. Lens AGE levels in patients with T2DM were negatively correlated with eGFR and positively correlated with urinary ACR. The animal and cell experiments showed that the AGE levels in the eyeballs of DM mice were also positively correlated with those in the serum and kidney. To increase the reliability of the experiment, we increased the sample size. In our results, lens AGEs levels were positively correlated with the occurrence of DKD, and the incidence of DKD in the high lens AGEs group was 2.739 times that in the low lens AGEs group. The receiver operating characteristic (ROC) curves showed that patients with T2DM with a lens AGEs value ≥ 0.306 were likely to have DKD. The area under the ROC curve of the noninvasive technique for identifying DKD was 0.757 (95% Cl: 0.677-0.838, p<0.001), and the sensitivity and specificity were 70.0% and 78.7%, respectively. These results suggest that noninvasive lens AGEs detection technology has certain clinical value in diagnosing whether patients with T2DM have DKD.

Engineering a highly selective leucine aminopeptidase near-infrared fluorescence probe for early diagnosis of diabetic nephropathy

Enhancing the Selectivity of Leucine Aminopeptidase Near-Infrared Fluorescent Probes for Assisting in Surgical Tumor Resection

Analysis of Urinary Proteomic Patterns for Diabetic Nephropathy by ProteinChip.

Near-infrared Fluorescent Read-out Probe for Ultra-Sensitive Imaging of Leucine Aminopeptidase in Vitro and in Vivo

Precisely Constructing Renal-Clearable and LAP-Activatable Ratiometric Molecular Probes for Early Diagnosis of Acute and Chronic Kidney Injury Via Optimizing Asymmetric DPP Dyes

A Novel Near-Infrared Fluorescent Probe for Real-Time Monitoring of Leucine Aminopeptidase Activity and Metastatic Tumor Progression

A Diketopyrrolopyrrole-Based Ratiometric Fluorescent Probe for Endogenous Leucine Aminopeptidase Detecting and Imaging with Specific Phototoxicity in Tumor Cells.

A novel aminopeptidase N triggered near-infrared fluorescence probe for imaging enzyme activity in cells and mice

Real-time imaging of alkaline phosphatase activity of diabetes in mice <i>via</i> a near-infrared fluorescent probe

Visualizing Detection of Diabetic Liver Injury by a Biomarker-Activatable Probe via NIR-II Fluorescence Imaging

In Situ imaging of orthotopic kidney cancer in the murine model using an aminopeptidase N activatable fluorescent probe

Rational Design of Fluorescent Probes: Improving Hydrophilicity, Ratiometric and NIR Trapping of Endogenous Leucine Aminopeptidase

Near-infrared microscopy reveals diabetic nephropathy in ob/ob mice

A Ratiometric Fluorescent Probe for Monitoring Leucine Aminopeptidase in Living Cells and Zebrafish Model.

Lipidomics Reveals Serum Specific Lipid Alterations in Diabetic Nephropathy

Visualization of Diabetes Progression by an Activatable NIR-IIb Luminescent Probe

High-contrast tumor imaging via a de novo designed aminopeptidase N targeted fluorogenic probe

An inherently kidney-targeting near-infrared fluorophore based probe for early detection of acute kidney injury

Real-Time Monitoring Renal Impairment Due to Drug-Induced AKI and Diabetes-Caused CKD Using an NAG-Activatable NIR-II Nanoprobe

Exploration of Noninvasive Detection of Advanced Glycation End Products in the Lens to Screen for Diabetic Kidney Disease

Fluorescent aptasensor based on G-quadruplex-assisted structural transformation for the detection of biomarker lipocalin 1.